178 related articles for article (PubMed ID: 15988755)
1. Simultaneous activation of JAK1 and JAK2 confers IL-3 independent growth on Ba/F3 pro-B cells.
Huang HM; Lin YL; Chen CH; Chang TW
J Cell Biochem; 2005 Oct; 96(2):361-75. PubMed ID: 15988755
[TBL] [Abstract][Full Text] [Related]
2. JAK pathway induction of c-Myc critical to IL-5 stimulation of cell proliferation and inhibition of apoptosis.
Lee WH; Liu FH; Lin JY; Huang SY; Lin H; Liao WJ; Huang HM
J Cell Biochem; 2009 Apr; 106(5):929-36. PubMed ID: 19180571
[TBL] [Abstract][Full Text] [Related]
3. The kinase domain of Jak2 mediates induction of bcl-2 and delays cell death in hematopoietic cells.
Sakai I; Kraft AS
J Biol Chem; 1997 May; 272(19):12350-8. PubMed ID: 9139679
[TBL] [Abstract][Full Text] [Related]
4. JAK1 N-terminus binds to conserved Box 1 and Box 2 motifs of cytokine receptor common beta subunit but signal activation requires JAK1 C-terminus.
Huang HM; Lee YL; Chang TW
J Cell Biochem; 2006 Nov; 99(4):1078-84. PubMed ID: 16767694
[TBL] [Abstract][Full Text] [Related]
5. Roles of JAK kinase in human GM-CSF receptor signals.
Watanabe S; Itoh T; Arai K
Leukemia; 1997 Apr; 11 Suppl 3():76-8. PubMed ID: 9209304
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction by a CD16/CD7/Jak2 fusion protein.
Sakai I; Nabell L; Kraft AS
J Biol Chem; 1995 Aug; 270(31):18420-7. PubMed ID: 7543102
[TBL] [Abstract][Full Text] [Related]
7. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
Yu WM; Hawley TS; Hawley RG; Qu CK
Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
9. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells.
Demoulin JB; Uyttenhove C; Lejeune D; Mui A; Groner B; Renauld JC
Cancer Res; 2000 Jul; 60(14):3971-7. PubMed ID: 10919676
[TBL] [Abstract][Full Text] [Related]
10. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of JAK2 confers murine interleukin-3-independent survival and proliferation of BA/F3 cells.
Liu CB; Itoh T; Arai K; Watanabe S
J Biol Chem; 1999 Mar; 274(10):6342-9. PubMed ID: 10037724
[TBL] [Abstract][Full Text] [Related]
12. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells.
Monni R; Santos SC; Mauchauffe M; Berger R; Ghysdael J; Gouilleux F; Gisselbrecht S; Bernard O; Penard-Lacronique V
Oncogene; 2001 Feb; 20(7):849-58. PubMed ID: 11314018
[TBL] [Abstract][Full Text] [Related]
13. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation.
Friedrich K; Kammer W; Erhardt I; Brändlein S; Sebald W; Moriggl R
Int Immunol; 1999 Aug; 11(8):1283-94. PubMed ID: 10421786
[TBL] [Abstract][Full Text] [Related]
14. Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor.
Dijkers PF; van Dijk TB; de Groot RP; Raaijmakers JA; Lammers JW; Koenderman L; Coffer PJ
Oncogene; 1999 Jun; 18(22):3334-42. PubMed ID: 10362354
[TBL] [Abstract][Full Text] [Related]
15. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.
Kirken RA; Rui H; Malabarba MG; Howard OM; Kawamura M; O'Shea JJ; Farrar WL
Cytokine; 1995 Oct; 7(7):689-700. PubMed ID: 8580378
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Jak2 tyrosine kinase by protein kinase C during macrophage differentiation of IL-3-dependent myeloid progenitor cells.
Kovanen PE; Junttila I; Takaluoma K; Saharinen P; Valmu L; Li W; Silvennoinen O
Blood; 2000 Mar; 95(5):1626-32. PubMed ID: 10688817
[TBL] [Abstract][Full Text] [Related]
17. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors.
Callus BA; Mathey-Prevot B
Blood; 1998 May; 91(9):3182-92. PubMed ID: 9558373
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
[TBL] [Abstract][Full Text] [Related]
20. Activation and functional analysis of Janus kinase 2 in BA/F3 cells using the coumermycin/gyrase B system.
Mohi MG; Arai Ki; Watanabe S
Mol Biol Cell; 1998 Dec; 9(12):3299-308. PubMed ID: 9843570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]